On Tuesday, TG Therapeutics Inc (NASDAQ: TGTX) opened higher 0.45% from the last session, before settling in for the closing price of $42.61. Price fluctuations for TGTX have ranged from $12.93 to $43.32 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2514.62% over the past five years. Company’s average yearly earnings per share was noted 549.52% at the time writing. With a float of $141.43 million, this company’s outstanding shares have now reached $155.84 million.
Let’s look at the performance matrix of the company that is accounted for 338 employees. In terms of profitability, gross margin is 88.26%, operating margin of 12.74%, and the pretax margin is 7.78%.
TG Therapeutics Inc (TGTX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of TG Therapeutics Inc is 9.96%, while institutional ownership is 62.27%. The most recent insider transaction that took place on Jan 03 ’25, was worth 343,443. In this transaction CFO of this company sold 11,337 shares at a rate of $30.29, taking the stock ownership to the 670,632 shares. Before that another transaction happened on Jan 06 ’25, when Company’s CFO sold 10,021 for $28.53, making the entire transaction worth $285,939. This insider now owns 660,611 shares in total.
TG Therapeutics Inc (TGTX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 549.52% per share during the next fiscal year.
TG Therapeutics Inc (NASDAQ: TGTX) Trading Performance Indicators
Check out the current performance indicators for TG Therapeutics Inc (TGTX). In the past quarter, the stock posted a quick ratio of 5.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.14, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach 1.93 in one year’s time.
Technical Analysis of TG Therapeutics Inc (TGTX)
TG Therapeutics Inc (NASDAQ: TGTX) saw its 5-day average volume 2.56 million, a negative change from its year-to-date volume of 2.69 million. As of the previous 9 days, the stock’s Stochastic %D was 92.77%. Additionally, its Average True Range was 2.08.
During the past 100 days, TG Therapeutics Inc’s (TGTX) raw stochastic average was set at 97.45%, which indicates a significant increase from 94.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.23% in the past 14 days, which was lower than the 68.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.68, while its 200-day Moving Average is $26.83. Nevertheless, the first resistance level for the watch stands at $43.10 in the near term. At $43.39, the stock is likely to face the second major resistance level. The third major resistance level sits at $43.95. If the price goes on to break the first support level at $42.24, it is likely to go to the next support level at $41.68. The third support level lies at $41.38 if the price breaches the second support level.
TG Therapeutics Inc (NASDAQ: TGTX) Key Stats
There are currently 157,071K shares outstanding in the company with a market cap of 6.72 billion. Presently, the company’s annual sales total 329,000 K according to its annual income of 23,380 K. Last quarter, the company’s sales amounted to 108,190 K and its income totaled 23,330 K.
